Showing results (181-190 of 196) with videos related to

Sort By:
Pageof 20
Targeted Oncology|March 22, 2019
Distribution of ALK Fusion Variants and Correlation with Clinical Outcomes in Chinese Patients with Non-Small Cell Lung Cancer Treated with CrizotinibYudong Su, Xiang Long, Yang Song, et al.
Translational Lung Cancer Research|June 15, 2026
Utilizing clinical features, genetic mutations, and a 14-gene molecular assay for optimizing the management of multiple primary lung cancerBowen Li, Zhibo Zheng, Zhina Wang, et al.
NPJ Precision Oncology|October 9, 2024
Super multiple primary lung cancers harbor high-frequency BRAF and low-frequency EGFR mutations in the MAPK pathwayHaochen Li, Zhicheng Huang, Chao Guo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 11, 2022
Health-Related Quality of Life Outcomes in Patients with Resected Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer Who Received Adjuvant Osimertinib in the Phase III ADAURA TrialMargarita Majem, Jonathan W Goldman, Thomas John, et al.
Translational Lung Cancer Research|April 23, 2021
HER2 transmembrane domain mutation: comprehensive characteristics and real-world evidence of treatment response in Chinese lung adenocarcinomaZiqi Jia, Jiahua Xing, Ji Li, et al.
Cancer Immunology, Immunotherapy : CII|April 26, 2024
Clonal expansion of shared T cell receptors reveals the existence of immune commonality among different lesions of synchronous multiple primary lung cancerYadong Wang, Zhicheng Huang, Bowen Li, et al.
Translational Lung Cancer Research|October 17, 2022
Comprehensive analysis of T cell receptor repertoire in patients with KRAS mutant non-small cell lung cancerYadong Wang, Ling Peng, Ming Zhao, et al.
Nature Biomedical Engineering|June 16, 2021
Ultrasensitive detection of circulating tumour DNA via deep methylation sequencing aided by machine learningNaixin Liang, Bingsi Li, Ziqi Jia, et al.
Thoracic Cancer|March 12, 2025
Chinese Expert Consensus on the Diagnosis and Treatment of Inflammatory Myofibroblastic TumorXiaoyan Si, Shafei Wu, Rui'e Feng, et al.
Clinical and Translational Medicine|February 5, 2025
Cell-free epigenomes enhanced fragmentomics-based model for early detection of lung cancerYadong Wang, Qiang Guo, Zhicheng Huang, et al.
Pageof 20